The Shoreview-based check printing and marketing company plans to buy all RDM common stock at a 14 percent premium.
latest articles
Subsidies are notoriously difficult to track, but here’s what we know.
The medtech company’s sales rose 11 percent year-over-year during the three-month period.
The unit could sell for as much as $5 billion, according to people familiar with the matter.
Howard Root, CEO of the medtech company, said the accusations have “no merit and we’ll prove it.”
The Brothers Snyder laud hometown’s buzzing bio-business startup scene.
Medtech firm went public in 2015.
Minnesotans pay $32 less than the national average for single coverage.
It would allow therapies to bypass ‘blood-brain barrier’ to treat neuro conditions.
Latest coffee fad is designed to expand coffee audience.
It marks the second time Austin-based Hormel has suspended Maschhoffs for animal cruelty claims in the last year.
There's been no contact between developers and state officials in months.
The Minneapolis startup was looking for a $100,000 investment in exchange for 20 percent stake.
You’ve grown up with the comic strip – but did you ever think about the lessons you learned from it?
Although the humble Minnesotan may be reluctant to admit it, Bravis’ contributions helped save thousands of lives and launch the largest medtech company in the world.
The rollback is due to “store performance” issues, according to an internal memo sent to affected employees.